Derivative Instruments (Tables)

9 Months Ended

Sep. 30, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Amounts and Locations of Activity Related to the Interest Rate Swaps Designated as Cash Flow Hedges within the Corporation's Consolidated Balance Sheet and Statement of Income

The following tables provide information about the amounts and locations of activity related to the interest rate swaps designated as cash flow hedges within the Corporation’s consolidated balance sheet and statement of income as of September 30, 2015 and December 31, 2014 and for the three and nine months ended September 30, 2015 and 2014:


		Fair value as of
	Balance Sheet	September 30,	December 31,
	Location	2015	2014
Interest rate contracts	Accrued interest and other liabilities	($908)	($	946	)


For the Three Months
Ended September 30, 2015		(a)		(b)		(c)		(d)		(e)
Interest rate contracts	($	19	)	Interest expense – subordinated debentures	($	95	)	Other income	$	0
For the Nine Months
Ended September 30, 2015		(a	)	(b)		(c)		(d)		(e)
Interest rate contracts	$	25		Interest expense – subordinated debentures	($	284	)	Other income	$	0
For the Three Months
Ended September 30, 2014		(a)		(b)		(c)		(d)		(e)
Interest rate contracts	$	99		Interest expense – subordinated debentures	($	96	)	Other income	$	0
For the Nine Months
Ended September 30, 2014		(a	)	(b)		(c)		(d)		(e)
Interest rate contracts	($	117	)	Interest expense – subordinated debentures	($	287	)	Other income	$	0

(a)	Amount of Gain or (Loss) Recognized in Other Comprehensive Loss on Derivative (Effective Portion), net of tax

(b)	Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion)

(c)	Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion)

(d)	Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing)

(e)	Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing)